A1D5I

6-[2-(5-bromanylpyrimidin-2-yl)oxyethoxy]-5-(4-bromophenyl)-~{N}-(propylsulfamoyl)pyrimidin-4-amine


Toggle HydrogenToggle Labels

Chemical Component Summary

Name6-[2-(5-bromanylpyrimidin-2-yl)oxyethoxy]-5-(4-bromophenyl)-~{N}-(propylsulfamoyl)pyrimidin-4-amine
SynonymsMacitentan
Identifiers6-[2-(5-bromanylpyrimidin-2-yl)oxyethoxy]-5-(4-bromophenyl)-~{N}-(propylsulfamoyl)pyrimidin-4-amine
FormulaC19 H20 Br2 N6 O4 S
Molecular Weight588.273
TypeNON-POLYMER
Isomeric SMILESCCCNS(=O)(=O)Nc1c(c(ncn1)OCCOc2ncc(cn2)Br)c3ccc(cc3)Br
InChIInChI=1S/C19H20Br2N6O4S/c1-2-7-26-32(28,29)27-17-16(13-3-5-14(20)6-4-13)18(25-12-24-17)30-8-9-31-19-22-10-15(21)11-23-19/h3-6,10-12,26H,2,7-9H2,1H3,(H,24,25,27)
InChIKeyJGCMEBMXRHSZKX-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count52
Chiral Atom Count0
Bond Count54
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB08932 
NameMacitentan
Groups approved
DescriptionMacitentan is a dual endothelin receptor antagonist used in the treatment of pulmonary arterial hypertension.[L35890] It was first approved by the FDA in 2013. Macitentan differs from its predecessor [bosentan] due to its lower risk of hepatotoxicity.
Synonyms
  • Macitentán
  • Macitentanum
  • Macitentan
Brand Names
  • Opsynvi
  • Opsumit
IndicationMacitentan is indicated for the treatment of WHO group 1 pulmonary arterial hypertension (PAH) both alone and in combination with tadalafil.[L35890, L39105]
Categories
  • Amides
  • Antihypertensive Agents
  • Antihypertensives for Pulmonary Arterial Hypertension
  • Cytochrome P-450 CYP2C19 Substrates
  • Cytochrome P-450 CYP2C8 Substrates
ATC-Code
  • C02KX04
  • C02KX54
CAS number441798-33-0

Drug Targets

NameTarget SequencePharmacological ActionActions
Endothelin-1 receptorMETLCLRASFWLALVGCVISDNPERYSTNLSNHVDDFTTFRGTELSFLVT...unknownantagonist
Endothelin B receptorMQPPPSLCGRALVALVLACGLSRIWGEERGFPPDRATPLLQTAEIMTPPT...unknownantagonist
Cytochrome P450 3A4MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...unknownsubstrate
Cytochrome P450 2C19MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...unknownsubstrate
Cytochrome P450 2C9MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682